World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
41801
World Ranking
8215
National Ranking
471

Michael Pawlita publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael Pawlita sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 534 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael Pawlita D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Pawlita sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael Pawlita is affiliated with the German Cancer Research Center in Germany. Their research primarily focuses on medicine, with significant contributions in epidemiology, otorhinolaryngology, surgery, oncology, and molecular biology.

The scientist's work frequently addresses key topics such as:

  • Head and Neck Cancer Studies
  • Cervical Cancer and HPV Research
  • Viral-associated cancers and disorders
  • Helicobacter pylori-related gastroenterology studies
  • Epigenetics and DNA Methylation
  • Genital Health and Disease
  • Cancer-related molecular mechanisms research

Michael Pawlita has contributed to numerous publications across well-recognized venues, including:

  • Cancer Epidemiology Biomarkers & Prevention
  • Laryngo-Rhino-Otologie
  • Clinical Epigenetics
  • Head & Neck
  • UNC Libraries

Among the scientist's recent papers are:

  • "Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women," 2020, Infectious Agents and Cancer
  • "Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI," 2020, Oral Oncology
  • "Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials," 2021, The Lancet Infectious Diseases
  • "Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank," 2020, EBioMedicine
  • "Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines," 2020, npj Vaccines

Frequent collaborators in their research include:

  • Tim Waterboer
  • Andy Ness
  • Nicole Brenner
  • Lea Schroeder
  • Miranda Pring

Best Publications

  • Case-control study of human papillomavirus and oropharyngeal cancer.

    Aimee R. Kreimer;Raphael Viscidi;Michael Pawlita;Carole Fakhry

  • Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.

    Frank C. Kischkel;Stefan Hellbardt;Iris Behrmann;Matthias Germer

  • Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

    Rolando Herrero;Xavier Castellsagué;Michael Pawlita;Jolanta Lissowska

  • Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.

    A. Oehm;I. Behrmann;Werner Falk;M. Pawlita

  • HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

    Xavier Castellsagué;Laia Alemany;Miquel Quer;Gordana Halec

  • A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.

    Serge J. Smeets;Albertus T. Hesselink;Ernst Jan M. Speel;Annick Haesevoets

  • Multiplex Human Papillomavirus Serology Based on In Situ-Purified Glutathione S-Transferase Fusion Proteins,

    Tim Waterboer;Peter Sehr;Kristina M. Michael;Silvia Franceschi

  • Bead-based multiplex genotyping of human papillomaviruses

    Markus Schmitt;I. G. Bravo;Peter J. F. Snijders;Lutz Gissmann

  • Biochemical engineering of the N-acyl side chain of sialic acid: biological implications.

    Oliver T. Keppler;Rüdiger Horstkorte;Michael Pawlita;Carolin Schmidt

  • Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva

    Silvia De Sanjosé;Laia Alemany;Jaume Ordi;Sara Tous

  • Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.

    Laia Alemany;Maëlle Saunier;Isabel Alvarado-Cabrero;Beatriz Quirós

  • UDP-GlcNAc 2-Epimerase: A Regulator of Cell Surface Sialylation

    Oliver T. Keppler;Stephan Hinderlich;Josmar Langner;Reinhard Schwartz-Albiez

  • Suppression of non-specific binding in serological Luminex assays.

    Tim Waterboer;Peter Sehr;Michael Pawlita

  • Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer

    Aimee R. Kreimer;Mattias Johansson;Tim Waterboer;Rudolf Kaaks

  • A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology

    Peter Sehr;Klaus Zumbach;Michael Pawlita

  • Human Papillomavirus Infection and Incidence of Squamous Cell and Basal Cell Carcinomas of the Skin

    Margaret R. Karagas;Heather H. Nelson;Peter Sehr;Tim Waterboer

  • Smoking as a major risk factor for cervical cancer and pre‐cancer: Results from the EPIC cohort

    Esther Roura;Xavier Castellsagué;Michael Pawlita;Noémie Travier

  • Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

    Sai Daayana;Eyad Elkord;U Winters;M Pawlita

  • Role of Human Papillomavirus in Penile Carcinomas Worldwide

    Laia Alemany;Antonio Cubilla;Gordana Halec;Elena Kasamatsu

  • The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.

    Gunnar Wichmann;Maciej Rosolowski;Knut Krohn;Markus Kreuz

Frequent Co-Authors

Tim Waterboer
Tim Waterboer German Cancer Research Center
Massimo Tommasino
Massimo Tommasino International Agency For Research On Cancer
Silvia de Sanjosé
Silvia de Sanjosé University of Barcelona
Silvia Franceschi
Silvia Franceschi Centro di Riferimento Oncologico
Andy R Ness
Andy R Ness University of Bristol
Paul Brennan
Paul Brennan International Agency For Research On Cancer
Wim Quint
Wim Quint Erasmus University Rotterdam
Wei Zheng
Wei Zheng Vanderbilt University Medical Center
Xavier Castellsagué
Xavier Castellsagué University of Barcelona
Adèle C. Green
Adèle C. Green QIMR Berghofer Medical Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond the traditional track of studying medicine in the USA, students can explore a variety of alternative online degrees and healthcare career options. These pathways are ideal for those seeking flexible study formats or faster entry into the medical workforce.

For example, individuals without a nursing background may consider online direct entry msn programs for non-nurses. These programs allow those with a bachelor’s degree in another field to pursue a Master of Science in Nursing and launch a new career in healthcare.

If you’re looking to start your nursing journey soon, some students opt for what is the easiest nursing program to get into, which can help you find nursing schools with higher acceptance rates and less stringent entry requirements. Additionally, there are nursing school without teas test for applicants who prefer programs without standardized exam prerequisites.

For those interested in healthcare administration, pursuing online medical billing and coding with financial aid can be an excellent way to enter a vital and growing field while maintaining financial flexibility.

Best Scientists Citing Michael Pawlita

Trending Scientists

Recently Published Articles